References:
1. Chen A, Coura-Filho GB, Rehder M. Clinical Characteristics of Covid-19 in China. N Engl J Med 2020;382:1860.
2. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. American Journal of Hematology 2020.
3. Zhang T, Sun LX, Feng RE. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:E040.
4. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis 2020.
5. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020;9:687-690.
6. Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 2020.
7. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Published January 28, 2020. Accessed January 31, 2020. https://www.who.int/publications-detai
8. National Health Commission of China. The diagnosis and treatment plan for the novel coronavirus disease (the seventh edition). 2020.
9. Coronavirus disease (COVID-2019) R&D. Geneva: World Health Organization. https://www.who.int/blueprint/ priority-diseases/key -action/novel -coronavirus/en/
10. Weitz JI, Fredenburgh JC, Eikelboom JW. A Test in Context: D-Dimer. Journal of the American College of Cardiology 2017;70:2411-2420.
11. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis 2020;18:844-847.
12. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020.
13. Oudkerk M, Buller HR, Kuijpers D, et al. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology 2020:201629.
14. Z Varga: Endothelial cell infection and endotheliitis in COVID-19. The Lancet’s website. https://www.thelancet.com/lancet/article/s0140-6736(20)30937-5. Published April 17, 2020. Assessed April 19,2020.
15. LEONARD-LORANT L, Xavier D, HELMS, et al. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels. Radiology 2020.
16. Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. The Lancet Haematology 2020;7:e362-e363.
17. Ji H, Zhao R, Matalon S, et al. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiological Reviews 2020;100:1065-1075.
18. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094-1099.
19. Lin L, Lu L, Cao W, et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 2020;9:727-732.